As weight loss medications containing active ingredients like semaglutide continue to define a new chapter in metabolic ...

Research shows semaglutide — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people ...

In April, Dr. Reddy’s Laboratories Ltd. became the first drug maker approved by Health Canada to sell a generic version of ...

“Semaglutide is very effective for weight loss,” says Dr. Saunders. In fact, a 2021 phase 3 clinical trial found that 2.4 ...

New research found semaglutide reduced major kidney disease risks by 24% in adults with Type 2 diabetes and chronic kidney ...

Objective: To compare the real-world effects of weekly injectable semaglutide (Ozempic) vs dulaglutide (Trulicity) on weight ...

The pharmaceutical sector continues to offer opportunities. Business Today TV's Shailendra Bhatnagar discussed with Vaibhav ...

Underlying diabetes and discontinuation rebound in mothers with overweight are likely responsible rather than the drug itself ...

The results support the potential to change the trajectory of kidney function decline and extend life expectancy.

New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide ...

Tirzepatide and semaglutide are popular weight loss drugs. Learn how they differ in effectiveness, cost, and side effects.

SAO PAULO, May 26 (Reuters) - Brazil's health regulator Anvisa said on Tuesday it had approved EMS's Ozivy, the country's ...